Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer

Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown biochemically about CRC, and with current treatments that are not wholly effective over time, new therapeutics are urgently needed. Emerging evidenc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Molecular biology reports Ročník 48; číslo 5; s. 4797 - 4811
Hlavní autoři: Moafian, Zeinab, Maghrouni, Abolfazl, Soltani, Arash, Hashemy, Seyed Isaac
Médium: Journal Article
Jazyk:angličtina
Vydáno: Dordrecht Springer Netherlands 01.05.2021
Springer Nature B.V
Témata:
1-Phosphatidylinositol 3-kinase
AKT protein
Animal Anatomy
Animal Biochemistry
Biomedical and Life Sciences
Cancer
Colorectal cancer
Colorectal carcinoma
colorectal neoplasms
Histology
Life Sciences
Metastases
metastasis
microRNA
molecular biology
Morphology
mortality
Non-coding RNA
Review
Therapeutic targets
therapeutics
TOR protein
mTOR pathway
AKT
PI3K
Colorectal cancer (CRC)
MicroRNAs
LncRNAs
ISSN:0301-4851, 1573-4978, 1573-4978
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown biochemically about CRC, and with current treatments that are not wholly effective over time, new therapeutics are urgently needed. Emerging evidence has shown the importance of non-coding RNAs such as lncRNAs and miRNAs functions in the development and progression of CRC. However, the exact underlying mechanism of these types of RNAs in CRC is still mostly unknown. PI3K/AKT/mTOR pathway contributes to many cellular processes, and dysregulation of this pathway frequently occurs in cancers. In this review, the authors have mostly focused on the significant non-coding RNAs regulators of the PI3K/AKT/mTOR pathway and their contribution to the development or inhibition of CRC and their potential as diagnostic or therapeutic targets in CRC treatment.
AbstractList Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown biochemically about CRC, and with current treatments that are not wholly effective over time, new therapeutics are urgently needed. Emerging evidence has shown the importance of non-coding RNAs such as lncRNAs and miRNAs functions in the development and progression of CRC. However, the exact underlying mechanism of these types of RNAs in CRC is still mostly unknown. PI3K/AKT/mTOR pathway contributes to many cellular processes, and dysregulation of this pathway frequently occurs in cancers. In this review, the authors have mostly focused on the significant non-coding RNAs regulators of the PI3K/AKT/mTOR pathway and their contribution to the development or inhibition of CRC and their potential as diagnostic or therapeutic targets in CRC treatment.
Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown biochemically about CRC, and with current treatments that are not wholly effective over time, new therapeutics are urgently needed. Emerging evidence has shown the importance of non-coding RNAs such as lncRNAs and miRNAs functions in the development and progression of CRC. However, the exact underlying mechanism of these types of RNAs in CRC is still mostly unknown. PI3K/AKT/mTOR pathway contributes to many cellular processes, and dysregulation of this pathway frequently occurs in cancers. In this review, the authors have mostly focused on the significant non-coding RNAs regulators of the PI3K/AKT/mTOR pathway and their contribution to the development or inhibition of CRC and their potential as diagnostic or therapeutic targets in CRC treatment.Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown biochemically about CRC, and with current treatments that are not wholly effective over time, new therapeutics are urgently needed. Emerging evidence has shown the importance of non-coding RNAs such as lncRNAs and miRNAs functions in the development and progression of CRC. However, the exact underlying mechanism of these types of RNAs in CRC is still mostly unknown. PI3K/AKT/mTOR pathway contributes to many cellular processes, and dysregulation of this pathway frequently occurs in cancers. In this review, the authors have mostly focused on the significant non-coding RNAs regulators of the PI3K/AKT/mTOR pathway and their contribution to the development or inhibition of CRC and their potential as diagnostic or therapeutic targets in CRC treatment.
Author Hashemy, Seyed Isaac
Maghrouni, Abolfazl
Soltani, Arash
Moafian, Zeinab
Author_xml – sequence: 1
  givenname: Zeinab
  surname: Moafian
  fullname: Moafian, Zeinab
  organization: Protein Chemistry Laboratory (PCL), Department of Biology, College of Sciences, Shiraz University of Medical Sciences
– sequence: 2
  givenname: Abolfazl
  surname: Maghrouni
  fullname: Maghrouni, Abolfazl
  organization: Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences
– sequence: 3
  givenname: Arash
  surname: Soltani
  fullname: Soltani, Arash
  organization: Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences
– sequence: 4
  givenname: Seyed Isaac
  orcidid: 0000-0002-1323-5250
  surname: Hashemy
  fullname: Hashemy, Seyed Isaac
  email: hashemyi@mums.ac.ir
  organization: Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Surgical Oncology Research Center, Mashhad University of Medical Sciences
BookMark eNqFkcFuEzEQhi1UJNLCC3CyxIWLyczaa3uPUQSlakWhCmfL67XLlo0d7I2qvD0OQULqoZx8-b5_xvOfk7OYoifkLcIHBFDLggicM2iQgRStZocXZIGt4kx0Sp-RBXBAJnSLr8h5KQ8AIFC1C_JtnVMpbLbTT9r7-dH7SGs2c2kY4z29-7Iq1MaBfr3i18vV9Wa53dze0Z2dfzzaAx0jdWlK2bsaQJ2NzufX5GWwU_Fv_r4X5Punj5v1Z3Zze3m1Xt0wx3U7sz4AdoE7FBjAcdlrLnqhwDohB4tdaxtoBghOq4DYd7qTOlgLbvBOORX4BXl_yt3l9Gvvy2y2Y3F-mmz0aV9MI-XxNCDl_9GWtwhaNryi756gD2mfY_1IpZRSQvAOKtWcKHe8XvbB7PK4tflgEMxxqjkVYmoh5k8h5lAl_URy42znMcU523F6XuUntdQ58d7nf1s9Y_0GA3ygCA
CitedBy_id crossref_primary_10_3389_fphar_2024_1494802
crossref_primary_10_3390_ijms231911616
crossref_primary_10_1007_s13659_023_00422_y
crossref_primary_10_1016_j_prp_2023_155015
crossref_primary_10_1007_s12032_025_02828_9
crossref_primary_10_1155_2022_8211941
crossref_primary_10_1007_s12672_023_00733_z
crossref_primary_10_2174_0118715206356311241128075924
crossref_primary_10_3390_ijms221910260
crossref_primary_10_1016_j_jep_2021_114412
crossref_primary_10_3390_ijms24032279
crossref_primary_10_1016_j_cbi_2024_111055
crossref_primary_10_1016_j_bbagrm_2023_194921
crossref_primary_10_1007_s12672_025_03476_1
crossref_primary_10_1186_s13287_025_04218_4
crossref_primary_10_1016_j_prp_2024_155546
crossref_primary_10_1016_j_intimp_2024_113529
crossref_primary_10_1186_s12885_021_08626_6
crossref_primary_10_1007_s12672_024_01250_3
crossref_primary_10_1016_j_tem_2023_02_008
crossref_primary_10_1016_j_tranon_2022_101609
crossref_primary_10_1002_cam4_7382
crossref_primary_10_3389_fcell_2024_1442193
crossref_primary_10_3390_cells11192940
crossref_primary_10_3389_fmolb_2024_1403727
crossref_primary_10_31083_j_fbl2802037
crossref_primary_10_3390_ijms25084548
Cites_doi 10.1016/j.biochi.2019.08.003
10.18632/aging.102929
10.1186/1471-230x-8-56
10.1101/gad.1048103
10.26355/eurrev_201907_18310
10.3892/or.2015.4450
10.1186/s13046-018-0994-x
10.1002/jcb.26000
10.1038/mtna.2015.5
10.1016/j.febslet.2014.03.037
10.1126/stke.3672007re1
10.1038/srep24720
10.1038/sj.bjc.6602970
10.1186/s13046-020-01622-x
10.18632/oncotarget.9320
10.1042/bsr20190249
10.1038/nrd4204
10.1146/annurev-biochem-051410-092902
10.1136/jmedgenet-2015-103334
10.1007/s12032-017-0897-2
10.1007/s12253-019-00743-9
10.1016/j.yexcr.2020.111939
10.3892/ol.2020.11516
10.1016/j.cellsig.2009.01.004
10.1002/ijc.32055
10.1186/s12935-019-0802-5
10.2147/ott.s229104
10.1002/1873-3468.13182
10.3892/ijmm.2015.2126
10.1016/j.trsl.2016.10.001
10.1017/erm.2014.23
10.3892/ol.2017.7715
10.1016/j.cell.2011.07.014
10.1007/s11033-020-05432-4
10.3390/cells8080803
10.1016/j.biopha.2018.11.105
10.14670/hh-18-081
10.2147/cmar.s194073
10.1111/jcmm.13522
10.2147/cmar.s255866
10.1016/j.biopha.2017.07.120
10.1007/s13277-013-0658-6
10.1093/nar/gkz097
10.1186/s13046-020-01562-6
10.1158/1078-0432.ccr-09-1249
10.1155/2016/5365209
10.1016/j.yexcr.2017.09.023
10.1245/s10434-014-4305-2
10.18632/oncotarget.3802
10.1002/mc.22752
10.1146/annurev-genet-120213-092323
10.3390/ijms19123711
10.7497/j.issn.2095-3941.2015.0006
10.1038/s41467-019-09649-1
10.1186/s12967-014-0244-8
10.1002/jcp.26276
10.1101/gad.1212704
10.1186/s12967-014-0231-0
10.26355/eurrev_201911_19551
10.1016/j.celrep.2015.07.016
10.1016/j.soc.2013.06.008
10.1158/2159-8290.cd-15-0460
10.1038/jhg.2016.91
10.3892/ijo.2013.2168
10.26355/eurrev_202004_21001
10.1016/j.bulcan.2017.12.009
10.1016/s0005-2760(98)00133-7
10.1038/nature12122
10.1002/mc.22710
10.3892/mmr.2017.7814
10.1016/j.molcel.2018.12.001
10.1016/j.critrevonc.2014.12.006
10.1038/nrg2521
10.3892/ol.2018.9506
10.1155/2017/7243968
10.1155/2016/9085195
10.1038/nrc.2017.99
10.1186/s13148-016-0305-3
10.1002/jcb.28401
10.22038/ijbms.2011.4988
10.1038/315239a0
10.1038/nrc1840
10.2147/ott.s226520
10.1080/10717544.2020.1716882
10.3892/or.2018.6806
10.1002/jcp.26891
10.1038/onc.2008.247
10.1146/annurev.cellbio.23.090506.123406
10.1016/j.molimm.2019.04.011
10.3892/ijmm.2018.3864
10.3892/or.2017.6054
10.1016/j.omtn.2020.03.006
10.1016/j.lfs.2019.02.049
10.1038/cddis.2017.352
10.1038/s41580-018-0015-0
10.1186/1476-4598-6-60
10.1007/s10620-017-4506-1
10.1016/j.bbamcr.2019.02.004
10.3892/mmr.2018.8857
10.1186/s12967-015-0592-z
10.1371/journal.pone.0081203
10.7150/jca.34650
10.3109/07853890.2014.912836
10.1007/s10620-017-4755-z
10.3892/ijo.2012.1707
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature B.V. 2021
The Author(s), under exclusive licence to Springer Nature B.V. 2021.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature B.V. 2021
– notice: The Author(s), under exclusive licence to Springer Nature B.V. 2021.
DBID AAYXX
CITATION
3V.
7TK
7TM
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
7S9
L.6
DOI 10.1007/s11033-021-06458-y
DatabaseName CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
ProQuest Health & Medical Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList ProQuest Central Student

AGRICOLA
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1573-4978
EndPage 4811
ExternalDocumentID 10_1007_s11033_021_06458_y
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
123
1SB
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88A
88E
88I
8AO
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LK8
LLZTM
M0L
M1P
M2P
M4Y
M7P
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z7Y
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8S
Z8V
Z8W
Z91
ZMTXR
ZOVNA
ZXP
~A9
~EX
~KM
AAPKM
AAYXX
ABAKF
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFFHD
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
7TK
7TM
7XB
8FD
8FK
FR3
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
7S9
L.6
PUEGO
ID FETCH-LOGICAL-c385t-bf019f3c141f0c36b834b470ac46da195a202d0fc87f11b98968faa0cdec7c7f3
IEDL.DBID RSV
ISICitedReferencesCount 30
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000656441100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0301-4851
1573-4978
IngestDate Thu Oct 02 11:10:57 EDT 2025
Sun Nov 09 14:36:39 EST 2025
Wed Nov 05 14:47:38 EST 2025
Sat Nov 29 05:10:20 EST 2025
Tue Nov 18 21:39:33 EST 2025
Fri Feb 21 02:48:29 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords mTOR pathway
AKT
PI3K
Colorectal cancer (CRC)
MicroRNAs
LncRNAs
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c385t-bf019f3c141f0c36b834b470ac46da195a202d0fc87f11b98968faa0cdec7c7f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-1323-5250
PQID 2577744390
PQPubID 54080
PageCount 15
ParticipantIDs proquest_miscellaneous_2661007066
proquest_miscellaneous_2535108623
proquest_journals_2577744390
crossref_primary_10_1007_s11033_021_06458_y
crossref_citationtrail_10_1007_s11033_021_06458_y
springer_journals_10_1007_s11033_021_06458_y
PublicationCentury 2000
PublicationDate 20210500
2021-05-00
20210501
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 5
  year: 2021
  text: 20210500
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
PublicationSubtitle An International Journal on Molecular and Cellular Biology
PublicationTitle Molecular biology reports
PublicationTitleAbbrev Mol Biol Rep
PublicationYear 2021
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Han, Li, Tang, Zhang, Guo, Hou, Huang (CR93) 2017; 360
Salmena, Poliseno, Tay, Kats, Pandolfi (CR50) 2011; 146
Gulhati, Cai, Li, Liu, Rychahou, Qiu, Lee, Silva, Bowen, Gao, Evers (CR44) 2009; 15
Jia, Luo, Ren, Li, Hu, Liu, Zhao, Shan, Zhou (CR82) 2017; 62
Lekka, Hall (CR11) 2018; 592
Benetatos, Voulgaris, Vartholomatos (CR46) 2017; 34
Karimi Roshan, Soltani, Soleimani, Rezaie Kahkhaie, Afshari, Soukhtanloo (CR28) 2019; 165
Cho (CR24) 2007; 6
Martini, De Santis, Braccini, Gulluni, Hirsch (CR36) 2014; 46
Weng, Wu, Yang, Peng, Wang, Wang, Li (CR6) 2017; 181
Hassan, Akcakanat, Holder, Meric-Bernstam (CR35) 2013; 22
Qi, Zhang, Wu, Xiao, Wang, Ma (CR51) 2015; 52
Anastasiadou, Jacob, Slack (CR8) 2018; 18
Liu, Dong, Ma, Wang, Lin, Li, Yang, Zhang, Zhang, Zhao (CR79) 2020; 27
Esquela-Kerscher, Slack (CR22) 2006; 6
Chamcheu, Roy, Uddin, Banang-Mbeumi, Chamcheu, Walker, Liu, Huang (CR41) 2019; 8
Liu, Liu, Zhao, Pan, Shan, Li, Jia (CR81) 2017; 56
Liang, Zhu, Zhu, Hou, Hou, Huang, Li, Wang, Li, Zou, Wu, Yao, Wang, Meng (CR99) 2019; 10
Wei, Tao, Zhang, Han, Zhu, Miao, Li, Qiao (CR90) 2015; 8
Song, Zhao, Ding, Wang (CR96) 2018; 8
Molasy, Walczak, Szaflik, Szaflik, Majsterek (CR25) 2017; 62
Liu, Zhou, Dong (CR98) 2019; 39
Liu, Gan, Chin, Ogura, Guo, Zhang, Wang, Blenis, Cantley, Toker, Su, Wei (CR38) 2015; 5
Xu, Xiao, Liu, Pan, Liu, Shan, Li, Qi, Huang, Jia (CR57) 2020; 39
Bonasio, Shiekhattar (CR15) 2014; 48
Yaghoubi, Soltani, Ghazvini, Hassanian, Hashemy (CR3) 2019; 110
Shi, Gao, Cao (CR17) 2016; 2016
Fruman, Rommel (CR31) 2014; 13
Coronel-Hernández, López-Urrutia, Contreras-Romero, Delgado-Waldo, Figueroa-González, Campos-Parra, Salgado-García, Martínez-Gutierrez, Rodríguez-Morales, Jacobo-Herrera, Terrazas, Silva-Carmona, López-Camarillo, Pérez-Plasencia (CR71) 2019; 19
Cowie, Hay, MacKenzie (CR7) 2015; 17
Araghi, Soerjomataram, Jenkins, Brierley, Morris, Bray, Arnold (CR1) 2019; 144
Bolha, Ravnik-Glavač, Glavač (CR16) 2017; 2017
Liu, Pan, Xiao, Liu, Xu, Jia (CR49) 2018; 37
Javid, Soltani, Mohammadi, Hashemy (CR30) 2019; 120
Cong, Li, Wei, Zhang, Xu (CR101) 2019; 23
Yang, Rudge, Koos, Vaidialingam, Yang, Pavletich (CR40) 2013; 497
Carracedo, Pandolfi (CR64) 2008; 27
Grillone, Riillo, Scionti, Rocca, Tradigo, Guzzi, Alcaro, Di Martino, Tagliaferri, Tassone (CR9) 2020; 39
Wu, Wei, Jiang, Tan, Xu, Fan, Zhang, Ding, Zhao, Shao, Zhang, Shi, Zhang, Wu (CR59) 2020; 20
Hiraki, Nishimura, Takahashi, Wu, Takahashi, Miyo, Nishida, Uemura, Hata, Takemasa, Mizushima, Soh, Doki, Mori, Yamamoto (CR104) 2015; 4
Chen, Jiang, Zhao, Luo, Liang, Zhen, Fu, Deng, Lin, Li, Luo, Liu, Fang (CR94) 2016; 7
Alessi, Downes (CR33) 1998; 1436
Yang, Shen, Yi, Zhang, Tang, Wang, Zhou, Zhou (CR47) 2018; 22
Balacescu, Sur, Cainap, Visan, Cruceriu, Manzat-Saplacan, Muresan, Balacescu, Lisencu, Irimie (CR27) 2018; 19
Papadatos-Pastos, Rabbie, Ross, Sarker (CR34) 2015; 94
Li, Ding, Liu, Sun, Zhang (CR102) 2017; 16
Yang, Murashige, Humphrey, James (CR43) 2015; 12
Lee, Gopalan, Lam (CR48) 2019; 34
Nagy, Wichmann, Kalmár, Galamb, Barták, Spisák, Tulassay, Molnár (CR26) 2017; 9
Zhou, Wu, Wang, Jiang, Li, Ma, Chen, Hou, Gan, Chen (CR52) 2018; 16
Li, Yang, Wang, Qiao, Guo, Zhang, Guo (CR76) 2020; 13
Whitman, Kaplan, Schaffhausen, Cantley, Roberts (CR32) 1985; 315
Liang, Gao, Li, Sun, Xu, Li, Jia, Zhao (CR75) 2017; 8
Hajjari, Salavaty (CR54) 2015; 12
Liu, Zhou, Feng, An, Quan, Wang, Ye, Yu, He, Luo (CR78) 2014; 44
Zhang, Li, Cao, Li, Zou, Li, Pei (CR103) 2019; 11
Zhang, Xiang, Wang, Duan, Liu, Jin, Zhang (CR92) 2017; 94
Soltani, Bahreyni, Boroumand, Mk, Khazaei, Ryzhikov, Soleimanpour, Avan, Hassanian (CR29) 2018; 233
Bai, Ma, Zhao, Li (CR58) 2020; 12
Dai, Yao, Zhang, Gu, Geng, Xue, Zhang (CR107) 2018; 105
Ni, Han, Jin (CR69) 2019; 12
Qiu, Hu, Yin, Xu (CR18) 2013; 34
Hashemy (CR2) 2011; 14
Liu, Xue, Du, Feng, Zhang, Zhang, Liu, Jia, Wu, Hu, Chen, Wang (CR68) 2019; 10
Pan, Liu, Liu, Xiao, Liu, Ren, Qi, Zhou, Zeng (CR106) 1866; 5
Liu, Wang, Tao, Li, Qin, Bai, Chi, Yan, Chen (CR108) 2019; 221
Zhou, Feng, Liu, Ye, Wang, Tan, Tian, Qiu, Luo (CR77) 2013; 8
Ke, Wang, Ke, Zou, Wang (CR56) 2020; 26
Zhang, Liu, Zhang, Xu, Shao, Hu, Shu, Cheng (CR67) 2020; 12
Bushati, Cohen (CR21) 2007; 23
Alles, Fehlmann, Fischer, Backes, Galata, Minet, Hart, Abu-Halima, Grässer, Lenhof, Keller, Meese (CR20) 2019; 47
Zhang, Shi, Tang, Fang, Wang, Cui (CR88) 2015; 35
Yang, Wang, Zhou, Chi (CR97) 2017; 38
Qin, Huo, Song, Chen, Tian, Wang (CR73) 2018; 15
Kovalski, Bhaduri, Zehnder, Neela, Che, Wozniak, Khavari (CR42) 2019; 73
Zhao, Sui, Zheng (CR109) 2016; 35
Sawai, Yasuda, Ochi, Ma, Matsuo, Wakasugi, Takahashi, Funahashi, Sato, Takeyama (CR66) 2008; 8
Memmott, Dennis (CR37) 2009; 21
Wang, Li, Zhao, Fan (CR83) 2018; 17
Zhang, Xu, Zhang, Sun, Li, Huang (CR100) 2020; 19
Dahariya, Paddibhatla, Kumar, Raghuwanshi, Pallepati, Gutti (CR12) 2019; 112
Hay, Sonenberg (CR39) 2004; 18
Karakas, Bachman, Park (CR63) 2006; 94
Ghazanchaei, Mansoori, Mohammadi, Biglari, Baradaran (CR84) 2018; 234
Losko, Kotlinowski, Jura (CR10) 2016; 2016
Dong, Konno, Watari, Hosaka, Noguchi, Sakuragi (CR45) 2014; 12
Xu, Zhang, Wang, Zhang, Ding, Zhao (CR61) 2014; 12
Wei, Cui, Mei, Liu, Zhang (CR86) 2014; 588
Rinn, Chang (CR14) 2012; 81
Zheng, Zhang, Liu, Zhou, Lu, Yuan, Zhang, Hong, Wang, Li (CR74) 2015; 13
Zhang, Zhong, Xiao, Chen (CR89) 2019; 41
Lorestani, Ghahremanloo, Jangjoo, Abedi, Hashemy (CR4) 2020; 47
Xiong, Cheng, Ma, Zhang (CR70) 2013; 42
Cui, Han, Wang, Li, Wang, Lv (CR53) 2019; 12
Qin, Qian (CR62) 2018; 42
El-Daly, Abba, Patil, Allgayer (CR80) 2016; 6
Richard Boland (CR5) 2017; 62
Mercer, Dinger, Mattick (CR13) 2009; 10
Jackson, Standart (CR19) 2007; 367
Lee, Chen, Pandolfi (CR65) 2018; 19
Ke, Wei, Yeh, Chen, Cheng (CR72) 2015; 22
Pan, Ren, Li, Liu, Li, Wang, Li, Dong, Guo (CR91) 2020; 390
Zhang, Li, Tan, Yu, Pei (CR85) 2017; 118
Slattery, Mullany, Sakoda, Wolff, Stevens, Samowitz, Herrick (CR105) 2018; 57
Zhao, Xu, Zhang (CR87) 2018; 10
Du, Liu, He, Liu, Qu, Yan, Fan, Li, Xi, Fu, Zhang, Yang, Hou (CR60) 2015; 6
Pei, Liu, Li, Zhang, Xu, Gao, Zhang, Li (CR55) 2019; 23
Cui, Chen, Wu, Hu, Qin (CR95) 2020; 24
Tang, Reinhart, Bartel, Zamore (CR23) 2003; 17
Y Liu (6458_CR68) 2019; 10
K Grillone (6458_CR9) 2020; 39
M Martini (6458_CR36) 2014; 46
B Karakas (6458_CR63) 2006; 94
M Losko (6458_CR10) 2016; 2016
Z Cui (6458_CR53) 2019; 12
B Liu (6458_CR49) 2018; 37
H Yang (6458_CR40) 2013; 497
A Qin (6458_CR62) 2018; 42
TW Ke (6458_CR72) 2015; 22
X Zhang (6458_CR85) 2017; 118
N Bai (6458_CR58) 2020; 12
J Coronel-Hernández (6458_CR71) 2019; 19
R Bonasio (6458_CR15) 2014; 48
WC Cho (6458_CR24) 2007; 6
MT Qiu (6458_CR18) 2013; 34
E Anastasiadou (6458_CR8) 2018; 18
FC Cui (6458_CR95) 2020; 24
S Pan (6458_CR106) 1866; 5
DR Alessi (6458_CR33) 1998; 1436
T Zhou (6458_CR52) 2018; 16
E Lekka (6458_CR11) 2018; 592
X Qi (6458_CR51) 2015; 52
P Liu (6458_CR38) 2015; 5
O Balacescu (6458_CR27) 2018; 19
P Cowie (6458_CR7) 2015; 17
M Molasy (6458_CR25) 2017; 62
SI Hashemy (6458_CR2) 2011; 14
JC Chamcheu (6458_CR41) 2019; 8
A Esquela-Kerscher (6458_CR22) 2006; 6
B Liu (6458_CR81) 2017; 56
Y Liang (6458_CR99) 2019; 10
Y Liu (6458_CR78) 2014; 44
Z Wei (6458_CR86) 2014; 588
K Cong (6458_CR101) 2019; 23
ML Slattery (6458_CR105) 2018; 57
S Lorestani (6458_CR4) 2020; 47
M Weng (6458_CR6) 2017; 181
RJ Jackson (6458_CR19) 2007; 367
J Han (6458_CR93) 2017; 360
A Soltani (6458_CR29) 2018; 233
YR Lee (6458_CR65) 2018; 19
ZJ Wei (6458_CR90) 2015; 8
Y Chen (6458_CR94) 2016; 7
B Hassan (6458_CR35) 2013; 22
L Salmena (6458_CR50) 2011; 146
Y Zhou (6458_CR77) 2013; 8
G Yang (6458_CR43) 2015; 12
C Yang (6458_CR97) 2017; 38
S Dahariya (6458_CR12) 2019; 112
L Zheng (6458_CR74) 2015; 13
H Liu (6458_CR108) 2019; 221
M Hajjari (6458_CR54) 2015; 12
AL Wang (6458_CR83) 2018; 17
J Alles (6458_CR20) 2019; 47
B Xiong (6458_CR70) 2013; 42
M Karimi Roshan (6458_CR28) 2019; 165
D Papadatos-Pastos (6458_CR34) 2015; 94
KT Lee (6458_CR48) 2019; 34
RM Memmott (6458_CR37) 2009; 21
Z Zhang (6458_CR89) 2019; 41
G Yang (6458_CR47) 2018; 22
Y Song (6458_CR96) 2018; 8
L Zhang (6458_CR103) 2019; 11
J Du (6458_CR60) 2015; 6
H Wu (6458_CR59) 2020; 20
G Tang (6458_CR23) 2003; 17
J Xu (6458_CR57) 2020; 39
Y Qin (6458_CR73) 2018; 15
TR Mercer (6458_CR13) 2009; 10
T Shi (6458_CR17) 2016; 2016
C Richard Boland (6458_CR5) 2017; 62
M Whitman (6458_CR32) 1985; 315
A Carracedo (6458_CR64) 2008; 27
S Pan (6458_CR91) 2020; 390
DA Fruman (6458_CR31) 2014; 13
Y Zhang (6458_CR92) 2017; 94
A Ghazanchaei (6458_CR84) 2018; 234
JR Kovalski (6458_CR42) 2019; 73
H Ni (6458_CR69) 2019; 12
L Jia (6458_CR82) 2017; 62
J Zhao (6458_CR87) 2018; 10
G Liu (6458_CR98) 2019; 39
L Xu (6458_CR61) 2014; 12
Y Zhang (6458_CR67) 2020; 12
N Yaghoubi (6458_CR3) 2019; 110
L Bolha (6458_CR16) 2017; 2017
X Li (6458_CR102) 2017; 16
Q Pei (6458_CR55) 2019; 23
N Bushati (6458_CR21) 2007; 23
P Gulhati (6458_CR44) 2009; 15
L Liang (6458_CR75) 2017; 8
N Hay (6458_CR39) 2004; 18
X Zhang (6458_CR88) 2015; 35
SM El-Daly (6458_CR80) 2016; 6
X Liu (6458_CR79) 2020; 27
G Dai (6458_CR107) 2018; 105
D Zhao (6458_CR109) 2016; 35
M Araghi (6458_CR1) 2019; 144
Y Li (6458_CR76) 2020; 13
H Javid (6458_CR30) 2019; 120
P Dong (6458_CR45) 2014; 12
JL Rinn (6458_CR14) 2012; 81
L Benetatos (6458_CR46) 2017; 34
D Ke (6458_CR56) 2020; 26
H Sawai (6458_CR66) 2008; 8
M Hiraki (6458_CR104) 2015; 4
X Zhang (6458_CR100) 2020; 19
ZB Nagy (6458_CR26) 2017; 9
References_xml – volume: 165
  start-page: 229
  year: 2019
  end-page: 234
  ident: CR28
  article-title: Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2019.08.003
– volume: 12
  start-page: 5640
  issue: 7
  year: 2020
  end-page: 5650
  ident: CR67
  article-title: Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway
  publication-title: Aging
  doi: 10.18632/aging.102929
– volume: 8
  start-page: 56
  year: 2008
  ident: CR66
  article-title: Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230x-8-56
– volume: 17
  start-page: 49
  issue: 1
  year: 2003
  end-page: 63
  ident: CR23
  article-title: A biochemical framework for RNA silencing in plants
  publication-title: Genes Dev
  doi: 10.1101/gad.1048103
– volume: 23
  start-page: 5730
  issue: 13
  year: 2019
  end-page: 5740
  ident: CR101
  article-title: MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_201907_18310
– volume: 35
  start-page: 1075
  issue: 2
  year: 2016
  end-page: 1082
  ident: CR109
  article-title: MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.4450
– volume: 37
  start-page: 316
  issue: 1
  year: 2018
  ident: CR49
  article-title: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-018-0994-x
– volume: 118
  start-page: 3435
  issue: 10
  year: 2017
  end-page: 3443
  ident: CR85
  article-title: STAT1 inhibits MiR-181a expression to suppress colorectal cancer cell proliferation through PTEN/Akt
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.26000
– volume: 4
  start-page: e231
  issue: 3
  year: 2015
  ident: CR104
  article-title: Concurrent targeting of KRAS and AKT by MiR-4689 is a novel treatment against mutant KRAS colorectal cancer
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1038/mtna.2015.5
– volume: 588
  start-page: 1773
  issue: 9
  year: 2014
  end-page: 1779
  ident: CR86
  article-title: miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2014.03.037
– volume: 367
  start-page: e1
  year: 2007
  ident: CR19
  article-title: How do microRNAs regulate gene expression? Science’s STKE: signal transduction knowledge environment
  publication-title: Sci Singal
  doi: 10.1126/stke.3672007re1
– volume: 12
  start-page: 808
  issue: 3
  year: 2019
  end-page: 816
  ident: CR69
  article-title: Celastrol inhibits colon cancer cell proliferation by downregulating miR-21 and PI3K/AKT/GSK-3β pathway
  publication-title: Int J Clin Exp Pathol
– volume: 6
  start-page: 24720
  year: 2016
  ident: CR80
  article-title: miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling
  publication-title: Sci Rep
  doi: 10.1038/srep24720
– volume: 94
  start-page: 455
  issue: 4
  year: 2006
  end-page: 459
  ident: CR63
  article-title: Mutation of the PIK3CA oncogene in human cancers
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602970
– volume: 39
  start-page: 117
  issue: 1
  year: 2020
  ident: CR9
  article-title: Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-020-01622-x
– volume: 7
  start-page: 41306
  issue: 27
  year: 2016
  end-page: 41319
  ident: CR94
  article-title: microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9320
– volume: 39
  start-page: 20190249
  issue: 3
  year: 2019
  ident: CR98
  article-title: Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway
  publication-title: Biosci Rep
  doi: 10.1042/bsr20190249
– volume: 13
  start-page: 140
  issue: 2
  year: 2014
  end-page: 156
  ident: CR31
  article-title: PI3K and cancer: lessons, challenges and opportunities
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd4204
– volume: 81
  start-page: 145
  year: 2012
  end-page: 166
  ident: CR14
  article-title: Genome regulation by long noncoding RNAs
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-051410-092902
– volume: 52
  start-page: 710
  issue: 10
  year: 2015
  end-page: 718
  ident: CR51
  article-title: ceRNA in cancer: possible functions and clinical implications
  publication-title: J Med Genet
  doi: 10.1136/jmedgenet-2015-103334
– volume: 34
  start-page: 39
  issue: 3
  year: 2017
  ident: CR46
  article-title: The crosstalk between long non-coding RNAs and PI3K in cancer
  publication-title: Med Oncol
  doi: 10.1007/s12032-017-0897-2
– volume: 26
  start-page: 1605
  issue: 3
  year: 2020
  end-page: 1613
  ident: CR56
  article-title: Long-non coding RNA SNHG16 supports colon cancer cell growth by modulating miR-302a-3p/AKT Axis
  publication-title: Pathol Oncol Res POR
  doi: 10.1007/s12253-019-00743-9
– volume: 390
  start-page: 111939
  issue: 1
  year: 2020
  ident: CR91
  article-title: MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2020.111939
– volume: 19
  start-page: 3923
  issue: 6
  year: 2020
  end-page: 3930
  ident: CR100
  article-title: MicroRNA-758 acts as a tumor inhibitor in colorectal cancer through targeting PAX6 and regulating PI3K/AKT pathway
  publication-title: Oncol Lett
  doi: 10.3892/ol.2020.11516
– volume: 21
  start-page: 656
  issue: 5
  year: 2009
  end-page: 664
  ident: CR37
  article-title: Akt-dependent and -independent mechanisms of mTOR regulation in cancer
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2009.01.004
– volume: 144
  start-page: 2992
  issue: 12
  year: 2019
  end-page: 3000
  ident: CR1
  article-title: Global trends in colorectal cancer mortality: projections to the year 2035
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32055
– volume: 19
  start-page: 80
  year: 2019
  ident: CR71
  article-title: Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axis
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-019-0802-5
– volume: 12
  start-page: 11531
  year: 2019
  end-page: 11539
  ident: CR53
  article-title: Long non-coding RNA TTN-AS1 promotes the proliferation and invasion of colorectal cancer cells by activating miR-497-mediated PI3K/Akt/mTOR signaling
  publication-title: Onco Targets Ther
  doi: 10.2147/ott.s229104
– volume: 592
  start-page: 2884
  issue: 17
  year: 2018
  end-page: 2900
  ident: CR11
  article-title: Noncoding RNAs in disease
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.13182
– volume: 35
  start-page: 1301
  issue: 5
  year: 2015
  end-page: 1308
  ident: CR88
  article-title: miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2015.2126
– volume: 181
  start-page: 108
  year: 2017
  end-page: 120
  ident: CR6
  article-title: Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer
  publication-title: Trans Res J Lab Clin Med
  doi: 10.1016/j.trsl.2016.10.001
– volume: 17
  start-page: e4
  year: 2015
  ident: CR7
  article-title: The noncoding human genome and the future of personalised medicine
  publication-title: Expert Rev Mol Med
  doi: 10.1017/erm.2014.23
– volume: 15
  start-page: 3197
  issue: 3
  year: 2018
  end-page: 3201
  ident: CR73
  article-title: mir-106a regulates cell proliferation and apoptosis of colon cancer cells through targeting the PTEN/PI3K/AKT signaling pathway
  publication-title: Oncol Lett
  doi: 10.3892/ol.2017.7715
– volume: 146
  start-page: 353
  issue: 3
  year: 2011
  end-page: 358
  ident: CR50
  article-title: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language
  publication-title: Cell
  doi: 10.1016/j.cell.2011.07.014
– volume: 47
  start-page: 3469
  issue: 5
  year: 2020
  end-page: 3474
  ident: CR4
  article-title: Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-020-05432-4
– volume: 8
  start-page: 803
  issue: 8
  year: 2019
  ident: CR41
  article-title: Role and therapeutic targeting of the PI3K/Akt/mTOR signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic agents therapy
  publication-title: Cells
  doi: 10.3390/cells8080803
– volume: 110
  start-page: 312
  year: 2019
  end-page: 318
  ident: CR3
  article-title: PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.11.105
– volume: 34
  start-page: 593
  issue: 6
  year: 2019
  end-page: 609
  ident: CR48
  article-title: Roles of long-non-coding RNAs in cancer therapy through the PI3K/Akt signalling pathway
  publication-title: Histol Histopathol
  doi: 10.14670/hh-18-081
– volume: 11
  start-page: 2769
  year: 2019
  end-page: 2781
  ident: CR103
  article-title: microRNA-877 inhibits malignant progression of colorectal cancer by directly targeting MTDH and regulating the PTEN/Akt pathway
  publication-title: Cancer Manage Res
  doi: 10.2147/cmar.s194073
– volume: 22
  start-page: 2062
  issue: 4
  year: 2018
  end-page: 2070
  ident: CR47
  article-title: Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13522
– volume: 12
  start-page: 4747
  year: 2020
  end-page: 4758
  ident: CR58
  article-title: Knockdown of lncRNA HCP5 suppresses the progression of colorectal cancer by miR-299-3p/PFN1/AKT axis
  publication-title: Cancer Manage Res
  doi: 10.2147/cmar.s255866
– volume: 94
  start-page: 644
  year: 2017
  end-page: 651
  ident: CR92
  article-title: lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.07.120
– volume: 34
  start-page: 613
  issue: 2
  year: 2013
  end-page: 620
  ident: CR18
  article-title: Long noncoding RNA: an emerging paradigm of cancer research
  publication-title: Tumour Biol J Inter Soc Oncodevelop Biol Med
  doi: 10.1007/s13277-013-0658-6
– volume: 47
  start-page: 3353
  issue: 7
  year: 2019
  end-page: 3364
  ident: CR20
  article-title: An estimate of the total number of true human miRNAs
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz097
– volume: 39
  start-page: 54
  issue: 1
  year: 2020
  ident: CR57
  article-title: Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-020-01562-6
– volume: 15
  start-page: 7207
  issue: 23
  year: 2009
  end-page: 7216
  ident: CR44
  article-title: Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.ccr-09-1249
– volume: 2016
  start-page: 5365209
  year: 2016
  ident: CR10
  article-title: Long noncoding RNAs in metabolic syndrome related disorders
  publication-title: Mediators Inflamm
  doi: 10.1155/2016/5365209
– volume: 360
  start-page: 328
  issue: 2
  year: 2017
  end-page: 336
  ident: CR93
  article-title: miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2017.09.023
– volume: 22
  start-page: 2649
  issue: 8
  year: 2015
  end-page: 2655
  ident: CR72
  article-title: MiR-92a promotes cell metastasis of colorectal cancer through PTEN-mediated PI3K/AKT pathway
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-014-4305-2
– volume: 6
  start-page: 14993
  issue: 17
  year: 2015
  end-page: 15007
  ident: CR60
  article-title: MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3802
– volume: 57
  start-page: 243
  issue: 2
  year: 2018
  end-page: 261
  ident: CR105
  article-title: The PI3K/AKT signaling pathway: associations of miRNAs with dysregulated gene expression in colorectal cancer
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22752
– volume: 48
  start-page: 433
  year: 2014
  end-page: 455
  ident: CR15
  article-title: Regulation of transcription by long noncoding RNAs
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev-genet-120213-092323
– volume: 19
  start-page: 3711
  issue: 12
  year: 2018
  ident: CR27
  article-title: The impact of miRNA in colorectal cancer progression and its liver metastases
  publication-title: Inter J Mol Sci
  doi: 10.3390/ijms19123711
– volume: 12
  start-page: 1
  issue: 1
  year: 2015
  end-page: 9
  ident: CR54
  article-title: HOTAIR: an oncogenic long non-coding RNA in different cancers
  publication-title: Cancer Biol Med
  doi: 10.7497/j.issn.2095-3941.2015.0006
– volume: 10
  start-page: 1637
  issue: 1
  year: 2019
  ident: CR68
  article-title: Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-09649-1
– volume: 12
  start-page: 244
  year: 2014
  ident: CR61
  article-title: Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway
  publication-title: J Transl Med
  doi: 10.1186/s12967-014-0244-8
– volume: 233
  start-page: 4783
  issue: 6
  year: 2018
  end-page: 4790
  ident: CR29
  article-title: Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.26276
– volume: 18
  start-page: 1926
  issue: 16
  year: 2004
  end-page: 1945
  ident: CR39
  article-title: Upstream and downstream of mTOR
  publication-title: Genes Dev
  doi: 10.1101/gad.1212704
– volume: 12
  start-page: 231
  year: 2014
  ident: CR45
  article-title: The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
  publication-title: J Transl Med
  doi: 10.1186/s12967-014-0231-0
– volume: 23
  start-page: 9871
  issue: 22
  year: 2019
  end-page: 9881
  ident: CR55
  article-title: Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_201911_19551
– volume: 12
  start-page: 937
  issue: 6
  year: 2015
  end-page: 943
  ident: CR43
  article-title: A positive feedback loop between Akt and mTORC2 via SIN1 phosphorylation
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2015.07.016
– volume: 22
  start-page: 641
  issue: 4
  year: 2013
  end-page: 664
  ident: CR35
  article-title: Targeting the PI3-kinase/Akt/mTOR signaling pathway
  publication-title: Surg Oncol Clin N Am
  doi: 10.1016/j.soc.2013.06.008
– volume: 5
  start-page: 1194
  issue: 11
  year: 2015
  end-page: 1209
  ident: CR38
  article-title: PtdIns(3,4,5)P3-dependent activation of the mTORC2 kinase complex
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.cd-15-0460
– volume: 62
  start-page: 105
  issue: 1
  year: 2017
  end-page: 112
  ident: CR25
  article-title: MicroRNAs in glaucoma and neurodegenerative diseases
  publication-title: J Hum Genet
  doi: 10.1038/jhg.2016.91
– volume: 44
  start-page: 203
  issue: 1
  year: 2014
  end-page: 210
  ident: CR78
  article-title: MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2013.2168
– volume: 8
  start-page: 4481
  issue: 5
  year: 2015
  end-page: 4491
  ident: CR90
  article-title: Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways
  publication-title: Int J Clin Exp Pathol
– volume: 24
  start-page: 4212
  issue: 8
  year: 2020
  end-page: 4223
  ident: CR95
  article-title: MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_202004_21001
– volume: 105
  start-page: 336
  issue: 4
  year: 2018
  end-page: 349
  ident: CR107
  article-title: Colorectal cancer cell-derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway
  publication-title: Bull Cancer
  doi: 10.1016/j.bulcan.2017.12.009
– volume: 1436
  start-page: 151
  issue: 1–2
  year: 1998
  end-page: 164
  ident: CR33
  article-title: The role of PI 3-kinase in insulin action
  publication-title: Biochem Biophys Acta
  doi: 10.1016/s0005-2760(98)00133-7
– volume: 497
  start-page: 217
  issue: 7448
  year: 2013
  end-page: 223
  ident: CR40
  article-title: mTOR kinase structure, mechanism and regulation
  publication-title: Nature
  doi: 10.1038/nature12122
– volume: 56
  start-page: 2669
  issue: 12
  year: 2017
  end-page: 2680
  ident: CR81
  article-title: Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22710
– volume: 16
  start-page: 9692
  issue: 6
  year: 2017
  end-page: 9700
  ident: CR102
  article-title: MicroRNA-760 inhibits cell proliferation and invasion of colorectal cancer by targeting the SP1-mediated PTEN/AKT signalling pathway
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2017.7814
– volume: 73
  start-page: 830
  issue: 4
  year: 2019
  end-page: 844.e812
  ident: CR42
  article-title: The functional proximal proteome of oncogenic Ras includes mTORC2
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2018.12.001
– volume: 94
  start-page: 18
  issue: 1
  year: 2015
  end-page: 30
  ident: CR34
  article-title: The role of the PI3K pathway in colorectal cancer
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2014.12.006
– volume: 10
  start-page: 155
  issue: 3
  year: 2009
  end-page: 159
  ident: CR13
  article-title: Long non-coding RNAs: insights into functions
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg2521
– volume: 16
  start-page: 6940
  issue: 6
  year: 2018
  end-page: 6949
  ident: CR52
  article-title: MicroRNA-128 targeting RPN2 inhibits cell proliferation and migration through the Akt-p53-cyclin pathway in colorectal cancer cells
  publication-title: Oncol Lett
  doi: 10.3892/ol.2018.9506
– volume: 2017
  start-page: 7243968
  year: 2017
  ident: CR16
  article-title: Long noncoding RNAs as biomarkers in cancer
  publication-title: Dis Markers
  doi: 10.1155/2017/7243968
– volume: 2016
  start-page: 9085195
  year: 2016
  ident: CR17
  article-title: Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics
  publication-title: Dis Markers
  doi: 10.1155/2016/9085195
– volume: 10
  start-page: 483
  issue: 2
  year: 2018
  end-page: 490
  ident: CR87
  article-title: SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt
  publication-title: Am J Trans Res
– volume: 18
  start-page: 5
  issue: 1
  year: 2018
  end-page: 18
  ident: CR8
  article-title: Non-coding RNA networks in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2017.99
– volume: 9
  start-page: 22
  year: 2017
  ident: CR26
  article-title: Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens
  publication-title: Clin Epigenetics
  doi: 10.1186/s13148-016-0305-3
– volume: 120
  start-page: 10874
  issue: 7
  year: 2019
  end-page: 10883
  ident: CR30
  article-title: Emerging roles of microRNAs in regulating the mTOR signaling pathway during tumorigenesis
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.28401
– volume: 14
  start-page: 191
  issue: 3
  year: 2011
  end-page: 204
  ident: CR2
  article-title: The human thioredoxin system: modifications and clinical applications
  publication-title: Iran J Basic Med Sci
  doi: 10.22038/ijbms.2011.4988
– volume: 315
  start-page: 239
  issue: 6016
  year: 1985
  end-page: 242
  ident: CR32
  article-title: Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation
  publication-title: Nature
  doi: 10.1038/315239a0
– volume: 6
  start-page: 259
  issue: 4
  year: 2006
  end-page: 269
  ident: CR22
  article-title: Oncomirs—microRNAs with a role in cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1840
– volume: 13
  start-page: 3501
  year: 2020
  end-page: 3510
  ident: CR76
  article-title: FNDC3B, targeted by miR-125a-5p and miR-217, promotes the proliferation and invasion of colorectal cancer cells via PI3K/mTOR signaling
  publication-title: Onco Targets Ther
  doi: 10.2147/ott.s226520
– volume: 27
  start-page: 323
  issue: 1
  year: 2020
  end-page: 333
  ident: CR79
  article-title: Nanocomplexes loaded with miR-128-3p for enhancing chemotherapy effect of colorectal cancer through dual-targeting silence the activity of PI3K/AKT and MEK/ERK pathway
  publication-title: Drug Deliv
  doi: 10.1080/10717544.2020.1716882
– volume: 41
  start-page: 619
  issue: 1
  year: 2019
  end-page: 629
  ident: CR89
  article-title: MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation
  publication-title: Oncol Rep
  doi: 10.3892/or.2018.6806
– volume: 234
  start-page: 769
  issue: 1
  year: 2018
  end-page: 776
  ident: CR84
  article-title: Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.26891
– volume: 27
  start-page: 5527
  issue: 41
  year: 2008
  end-page: 5541
  ident: CR64
  article-title: The PTEN-PI3K pathway: of feedbacks and cross-talks
  publication-title: Oncogene
  doi: 10.1038/onc.2008.247
– volume: 23
  start-page: 175
  year: 2007
  end-page: 205
  ident: CR21
  article-title: microRNA functions
  publication-title: Annu Rev Cell Dev Biol
  doi: 10.1146/annurev.cellbio.23.090506.123406
– volume: 112
  start-page: 82
  year: 2019
  end-page: 92
  ident: CR12
  article-title: Long non-coding RNA: classification, biogenesis and functions in blood cells
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2019.04.011
– volume: 42
  start-page: 2503
  issue: 5
  year: 2018
  end-page: 2514
  ident: CR62
  article-title: MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2018.3864
– volume: 38
  start-page: 3545
  issue: 6
  year: 2017
  end-page: 3553
  ident: CR97
  article-title: Upregulation of miR-542-3p inhibits the growth and invasion of human colon cancer cells through PI3K/AKT/survivin signaling
  publication-title: Oncol Rep
  doi: 10.3892/or.2017.6054
– volume: 20
  start-page: 438
  year: 2020
  end-page: 450
  ident: CR59
  article-title: lncRNA PVT1 promotes tumorigenesis of colorectal cancer by stabilizing miR-16-5p and interacting with the VEGFA/VEGFR1/AKT axis
  publication-title: Mol Therapy Nucleic Acids
  doi: 10.1016/j.omtn.2020.03.006
– volume: 221
  start-page: 354
  year: 2019
  end-page: 361
  ident: CR108
  article-title: Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.02.049
– volume: 8
  start-page: e2968
  issue: 8
  year: 2017
  ident: CR75
  article-title: miR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation, migration, invasion and pathological angiogenesis via PI3K-Akt pathway
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.352
– volume: 19
  start-page: 547
  issue: 9
  year: 2018
  end-page: 562
  ident: CR65
  article-title: The functions and regulation of the PTEN tumour suppressor: new modes and prospects
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-018-0015-0
– volume: 6
  start-page: 60
  year: 2007
  ident: CR24
  article-title: OncomiRs: the discovery and progress of microRNAs in cancers
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-6-60
– volume: 62
  start-page: 1107
  issue: 5
  year: 2017
  end-page: 1109
  ident: CR5
  article-title: Non-coding RNA: it’s not junk
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-017-4506-1
– volume: 5
  start-page: 750
  year: 1866
  end-page: 760
  ident: CR106
  article-title: Jia L (2019) HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2019.02.004
– volume: 17
  start-page: 7721
  issue: 6
  year: 2018
  end-page: 7729
  ident: CR83
  article-title: Formononetin inhibits colon carcinoma cell growth and invasion by microRNA-149-mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2018.8857
– volume: 8
  start-page: 435
  issue: 3
  year: 2018
  end-page: 449
  ident: CR96
  article-title: microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R
  publication-title: Am J Cancer Res
– volume: 13
  start-page: 252
  year: 2015
  ident: CR74
  article-title: MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
  publication-title: J Transl Med
  doi: 10.1186/s12967-015-0592-z
– volume: 8
  start-page: e81203
  issue: 11
  year: 2013
  ident: CR77
  article-title: Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0081203
– volume: 10
  start-page: 6037
  issue: 24
  year: 2019
  end-page: 6047
  ident: CR99
  article-title: Dichloroacetate overcomes oxaliplatin chemoresistance in colorectal cancer through the miR-543/PTEN/Akt/mTOR pathway
  publication-title: J Cancer
  doi: 10.7150/jca.34650
– volume: 46
  start-page: 372
  issue: 6
  year: 2014
  end-page: 383
  ident: CR36
  article-title: PI3K/AKT signaling pathway and cancer: an updated review
  publication-title: Ann Med
  doi: 10.3109/07853890.2014.912836
– volume: 62
  start-page: 3447
  issue: 12
  year: 2017
  end-page: 3459
  ident: CR82
  article-title: miR-182 and miR-135b mediate the tumorigenesis and invasiveness of colorectal cancer cells via targeting ST6GALNAC2 and PI3K/AKT pathway
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-017-4755-z
– volume: 42
  start-page: 219
  issue: 1
  year: 2013
  end-page: 228
  ident: CR70
  article-title: MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2012.1707
– volume: 12
  start-page: 231
  year: 2014
  ident: 6458_CR45
  publication-title: J Transl Med
  doi: 10.1186/s12967-014-0231-0
– volume: 19
  start-page: 547
  issue: 9
  year: 2018
  ident: 6458_CR65
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-018-0015-0
– volume: 38
  start-page: 3545
  issue: 6
  year: 2017
  ident: 6458_CR97
  publication-title: Oncol Rep
  doi: 10.3892/or.2017.6054
– volume: 360
  start-page: 328
  issue: 2
  year: 2017
  ident: 6458_CR93
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2017.09.023
– volume: 46
  start-page: 372
  issue: 6
  year: 2014
  ident: 6458_CR36
  publication-title: Ann Med
  doi: 10.3109/07853890.2014.912836
– volume: 120
  start-page: 10874
  issue: 7
  year: 2019
  ident: 6458_CR30
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.28401
– volume: 221
  start-page: 354
  year: 2019
  ident: 6458_CR108
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.02.049
– volume: 81
  start-page: 145
  year: 2012
  ident: 6458_CR14
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-051410-092902
– volume: 12
  start-page: 1
  issue: 1
  year: 2015
  ident: 6458_CR54
  publication-title: Cancer Biol Med
  doi: 10.7497/j.issn.2095-3941.2015.0006
– volume: 34
  start-page: 613
  issue: 2
  year: 2013
  ident: 6458_CR18
  publication-title: Tumour Biol J Inter Soc Oncodevelop Biol Med
  doi: 10.1007/s13277-013-0658-6
– volume: 16
  start-page: 9692
  issue: 6
  year: 2017
  ident: 6458_CR102
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2017.7814
– volume: 22
  start-page: 2062
  issue: 4
  year: 2018
  ident: 6458_CR47
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13522
– volume: 17
  start-page: 49
  issue: 1
  year: 2003
  ident: 6458_CR23
  publication-title: Genes Dev
  doi: 10.1101/gad.1048103
– volume: 10
  start-page: 1637
  issue: 1
  year: 2019
  ident: 6458_CR68
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-09649-1
– volume: 588
  start-page: 1773
  issue: 9
  year: 2014
  ident: 6458_CR86
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2014.03.037
– volume: 8
  start-page: e2968
  issue: 8
  year: 2017
  ident: 6458_CR75
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2017.352
– volume: 62
  start-page: 3447
  issue: 12
  year: 2017
  ident: 6458_CR82
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-017-4755-z
– volume: 39
  start-page: 20190249
  issue: 3
  year: 2019
  ident: 6458_CR98
  publication-title: Biosci Rep
  doi: 10.1042/bsr20190249
– volume: 17
  start-page: 7721
  issue: 6
  year: 2018
  ident: 6458_CR83
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2018.8857
– volume: 35
  start-page: 1301
  issue: 5
  year: 2015
  ident: 6458_CR88
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2015.2126
– volume: 233
  start-page: 4783
  issue: 6
  year: 2018
  ident: 6458_CR29
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.26276
– volume: 13
  start-page: 3501
  year: 2020
  ident: 6458_CR76
  publication-title: Onco Targets Ther
  doi: 10.2147/ott.s226520
– volume: 8
  start-page: 803
  issue: 8
  year: 2019
  ident: 6458_CR41
  publication-title: Cells
  doi: 10.3390/cells8080803
– volume: 6
  start-page: 60
  year: 2007
  ident: 6458_CR24
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-6-60
– volume: 16
  start-page: 6940
  issue: 6
  year: 2018
  ident: 6458_CR52
  publication-title: Oncol Lett
  doi: 10.3892/ol.2018.9506
– volume: 18
  start-page: 5
  issue: 1
  year: 2018
  ident: 6458_CR8
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc.2017.99
– volume: 110
  start-page: 312
  year: 2019
  ident: 6458_CR3
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.11.105
– volume: 10
  start-page: 483
  issue: 2
  year: 2018
  ident: 6458_CR87
  publication-title: Am J Trans Res
– volume: 39
  start-page: 117
  issue: 1
  year: 2020
  ident: 6458_CR9
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-020-01622-x
– volume: 234
  start-page: 769
  issue: 1
  year: 2018
  ident: 6458_CR84
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.26891
– volume: 12
  start-page: 937
  issue: 6
  year: 2015
  ident: 6458_CR43
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2015.07.016
– volume: 5
  start-page: 1194
  issue: 11
  year: 2015
  ident: 6458_CR38
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.cd-15-0460
– volume: 94
  start-page: 18
  issue: 1
  year: 2015
  ident: 6458_CR34
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2014.12.006
– volume: 12
  start-page: 4747
  year: 2020
  ident: 6458_CR58
  publication-title: Cancer Manage Res
  doi: 10.2147/cmar.s255866
– volume: 6
  start-page: 14993
  issue: 17
  year: 2015
  ident: 6458_CR60
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3802
– volume: 118
  start-page: 3435
  issue: 10
  year: 2017
  ident: 6458_CR85
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.26000
– volume: 52
  start-page: 710
  issue: 10
  year: 2015
  ident: 6458_CR51
  publication-title: J Med Genet
  doi: 10.1136/jmedgenet-2015-103334
– volume: 8
  start-page: 56
  year: 2008
  ident: 6458_CR66
  publication-title: BMC Gastroenterol
  doi: 10.1186/1471-230x-8-56
– volume: 22
  start-page: 2649
  issue: 8
  year: 2015
  ident: 6458_CR72
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-014-4305-2
– volume: 497
  start-page: 217
  issue: 7448
  year: 2013
  ident: 6458_CR40
  publication-title: Nature
  doi: 10.1038/nature12122
– volume: 17
  start-page: e4
  year: 2015
  ident: 6458_CR7
  publication-title: Expert Rev Mol Med
  doi: 10.1017/erm.2014.23
– volume: 146
  start-page: 353
  issue: 3
  year: 2011
  ident: 6458_CR50
  publication-title: Cell
  doi: 10.1016/j.cell.2011.07.014
– volume: 21
  start-page: 656
  issue: 5
  year: 2009
  ident: 6458_CR37
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2009.01.004
– volume: 57
  start-page: 243
  issue: 2
  year: 2018
  ident: 6458_CR105
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22752
– volume: 37
  start-page: 316
  issue: 1
  year: 2018
  ident: 6458_CR49
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-018-0994-x
– volume: 62
  start-page: 1107
  issue: 5
  year: 2017
  ident: 6458_CR5
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-017-4506-1
– volume: 2017
  start-page: 7243968
  year: 2017
  ident: 6458_CR16
  publication-title: Dis Markers
  doi: 10.1155/2017/7243968
– volume: 105
  start-page: 336
  issue: 4
  year: 2018
  ident: 6458_CR107
  publication-title: Bull Cancer
  doi: 10.1016/j.bulcan.2017.12.009
– volume: 35
  start-page: 1075
  issue: 2
  year: 2016
  ident: 6458_CR109
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.4450
– volume: 15
  start-page: 7207
  issue: 23
  year: 2009
  ident: 6458_CR44
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.ccr-09-1249
– volume: 1436
  start-page: 151
  issue: 1–2
  year: 1998
  ident: 6458_CR33
  publication-title: Biochem Biophys Acta
  doi: 10.1016/s0005-2760(98)00133-7
– volume: 592
  start-page: 2884
  issue: 17
  year: 2018
  ident: 6458_CR11
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.13182
– volume: 6
  start-page: 259
  issue: 4
  year: 2006
  ident: 6458_CR22
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1840
– volume: 48
  start-page: 433
  year: 2014
  ident: 6458_CR15
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev-genet-120213-092323
– volume: 23
  start-page: 9871
  issue: 22
  year: 2019
  ident: 6458_CR55
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_201911_19551
– volume: 27
  start-page: 5527
  issue: 41
  year: 2008
  ident: 6458_CR64
  publication-title: Oncogene
  doi: 10.1038/onc.2008.247
– volume: 19
  start-page: 80
  year: 2019
  ident: 6458_CR71
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-019-0802-5
– volume: 7
  start-page: 41306
  issue: 27
  year: 2016
  ident: 6458_CR94
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9320
– volume: 181
  start-page: 108
  year: 2017
  ident: 6458_CR6
  publication-title: Trans Res J Lab Clin Med
  doi: 10.1016/j.trsl.2016.10.001
– volume: 112
  start-page: 82
  year: 2019
  ident: 6458_CR12
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2019.04.011
– volume: 15
  start-page: 3197
  issue: 3
  year: 2018
  ident: 6458_CR73
  publication-title: Oncol Lett
  doi: 10.3892/ol.2017.7715
– volume: 62
  start-page: 105
  issue: 1
  year: 2017
  ident: 6458_CR25
  publication-title: J Hum Genet
  doi: 10.1038/jhg.2016.91
– volume: 73
  start-page: 830
  issue: 4
  year: 2019
  ident: 6458_CR42
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2018.12.001
– volume: 315
  start-page: 239
  issue: 6016
  year: 1985
  ident: 6458_CR32
  publication-title: Nature
  doi: 10.1038/315239a0
– volume: 12
  start-page: 244
  year: 2014
  ident: 6458_CR61
  publication-title: J Transl Med
  doi: 10.1186/s12967-014-0244-8
– volume: 390
  start-page: 111939
  issue: 1
  year: 2020
  ident: 6458_CR91
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2020.111939
– volume: 23
  start-page: 5730
  issue: 13
  year: 2019
  ident: 6458_CR101
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_201907_18310
– volume: 94
  start-page: 455
  issue: 4
  year: 2006
  ident: 6458_CR63
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602970
– volume: 13
  start-page: 252
  year: 2015
  ident: 6458_CR74
  publication-title: J Transl Med
  doi: 10.1186/s12967-015-0592-z
– volume: 11
  start-page: 2769
  year: 2019
  ident: 6458_CR103
  publication-title: Cancer Manage Res
  doi: 10.2147/cmar.s194073
– volume: 9
  start-page: 22
  year: 2017
  ident: 6458_CR26
  publication-title: Clin Epigenetics
  doi: 10.1186/s13148-016-0305-3
– volume: 42
  start-page: 2503
  issue: 5
  year: 2018
  ident: 6458_CR62
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2018.3864
– volume: 26
  start-page: 1605
  issue: 3
  year: 2020
  ident: 6458_CR56
  publication-title: Pathol Oncol Res POR
  doi: 10.1007/s12253-019-00743-9
– volume: 10
  start-page: 155
  issue: 3
  year: 2009
  ident: 6458_CR13
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg2521
– volume: 19
  start-page: 3711
  issue: 12
  year: 2018
  ident: 6458_CR27
  publication-title: Inter J Mol Sci
  doi: 10.3390/ijms19123711
– volume: 47
  start-page: 3469
  issue: 5
  year: 2020
  ident: 6458_CR4
  publication-title: Mol Biol Rep
  doi: 10.1007/s11033-020-05432-4
– volume: 144
  start-page: 2992
  issue: 12
  year: 2019
  ident: 6458_CR1
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32055
– volume: 13
  start-page: 140
  issue: 2
  year: 2014
  ident: 6458_CR31
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd4204
– volume: 2016
  start-page: 5365209
  year: 2016
  ident: 6458_CR10
  publication-title: Mediators Inflamm
  doi: 10.1155/2016/5365209
– volume: 47
  start-page: 3353
  issue: 7
  year: 2019
  ident: 6458_CR20
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz097
– volume: 39
  start-page: 54
  issue: 1
  year: 2020
  ident: 6458_CR57
  publication-title: J Exp Clin Cancer Res CR
  doi: 10.1186/s13046-020-01562-6
– volume: 8
  start-page: 435
  issue: 3
  year: 2018
  ident: 6458_CR96
  publication-title: Am J Cancer Res
– volume: 34
  start-page: 39
  issue: 3
  year: 2017
  ident: 6458_CR46
  publication-title: Med Oncol
  doi: 10.1007/s12032-017-0897-2
– volume: 94
  start-page: 644
  year: 2017
  ident: 6458_CR92
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.07.120
– volume: 22
  start-page: 641
  issue: 4
  year: 2013
  ident: 6458_CR35
  publication-title: Surg Oncol Clin N Am
  doi: 10.1016/j.soc.2013.06.008
– volume: 8
  start-page: 4481
  issue: 5
  year: 2015
  ident: 6458_CR90
  publication-title: Int J Clin Exp Pathol
– volume: 4
  start-page: e231
  issue: 3
  year: 2015
  ident: 6458_CR104
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1038/mtna.2015.5
– volume: 20
  start-page: 438
  year: 2020
  ident: 6458_CR59
  publication-title: Mol Therapy Nucleic Acids
  doi: 10.1016/j.omtn.2020.03.006
– volume: 24
  start-page: 4212
  issue: 8
  year: 2020
  ident: 6458_CR95
  publication-title: Eur Rev Med Pharmacol Sci
  doi: 10.26355/eurrev_202004_21001
– volume: 12
  start-page: 808
  issue: 3
  year: 2019
  ident: 6458_CR69
  publication-title: Int J Clin Exp Pathol
– volume: 2016
  start-page: 9085195
  year: 2016
  ident: 6458_CR17
  publication-title: Dis Markers
  doi: 10.1155/2016/9085195
– volume: 6
  start-page: 24720
  year: 2016
  ident: 6458_CR80
  publication-title: Sci Rep
  doi: 10.1038/srep24720
– volume: 27
  start-page: 323
  issue: 1
  year: 2020
  ident: 6458_CR79
  publication-title: Drug Deliv
  doi: 10.1080/10717544.2020.1716882
– volume: 12
  start-page: 5640
  issue: 7
  year: 2020
  ident: 6458_CR67
  publication-title: Aging
  doi: 10.18632/aging.102929
– volume: 19
  start-page: 3923
  issue: 6
  year: 2020
  ident: 6458_CR100
  publication-title: Oncol Lett
  doi: 10.3892/ol.2020.11516
– volume: 367
  start-page: e1
  year: 2007
  ident: 6458_CR19
  publication-title: Sci Singal
  doi: 10.1126/stke.3672007re1
– volume: 165
  start-page: 229
  year: 2019
  ident: 6458_CR28
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2019.08.003
– volume: 44
  start-page: 203
  issue: 1
  year: 2014
  ident: 6458_CR78
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2013.2168
– volume: 34
  start-page: 593
  issue: 6
  year: 2019
  ident: 6458_CR48
  publication-title: Histol Histopathol
  doi: 10.14670/hh-18-081
– volume: 5
  start-page: 750
  year: 1866
  ident: 6458_CR106
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2019.02.004
– volume: 18
  start-page: 1926
  issue: 16
  year: 2004
  ident: 6458_CR39
  publication-title: Genes Dev
  doi: 10.1101/gad.1212704
– volume: 10
  start-page: 6037
  issue: 24
  year: 2019
  ident: 6458_CR99
  publication-title: J Cancer
  doi: 10.7150/jca.34650
– volume: 12
  start-page: 11531
  year: 2019
  ident: 6458_CR53
  publication-title: Onco Targets Ther
  doi: 10.2147/ott.s229104
– volume: 56
  start-page: 2669
  issue: 12
  year: 2017
  ident: 6458_CR81
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22710
– volume: 14
  start-page: 191
  issue: 3
  year: 2011
  ident: 6458_CR2
  publication-title: Iran J Basic Med Sci
  doi: 10.22038/ijbms.2011.4988
– volume: 42
  start-page: 219
  issue: 1
  year: 2013
  ident: 6458_CR70
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2012.1707
– volume: 8
  start-page: e81203
  issue: 11
  year: 2013
  ident: 6458_CR77
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0081203
– volume: 23
  start-page: 175
  year: 2007
  ident: 6458_CR21
  publication-title: Annu Rev Cell Dev Biol
  doi: 10.1146/annurev.cellbio.23.090506.123406
– volume: 41
  start-page: 619
  issue: 1
  year: 2019
  ident: 6458_CR89
  publication-title: Oncol Rep
  doi: 10.3892/or.2018.6806
SSID ssj0004175
Score 2.411422
SecondaryResourceType review_article
Snippet Colorectal cancer (CRC) is the third commonest cancer globally, with metastasis being the reason for cancer-associated mortality. Much is still unknown...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 4797
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
Animal Anatomy
Animal Biochemistry
Biomedical and Life Sciences
Cancer
Colorectal cancer
Colorectal carcinoma
colorectal neoplasms
Histology
Life Sciences
Metastases
metastasis
microRNA
molecular biology
Morphology
mortality
Non-coding RNA
Review
Therapeutic targets
therapeutics
TOR protein
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7StCW99JEmZNu0KNBbK9aybD1OJSwNDYXtJqSQm5H1gNDGm-xuEvbfV-OVY1LIXnq2jAbNWPNZmvk-gE9SuUIw5qgWNtBC-YKaMje01HWMZi08c6YVm5DjsTo_15N04DZPZZXdnthu1G5q8Yx8GEMrIpWYPrOvV9cUVaPwdjVJaDyBp8iSwNvSvUnfF8laol1E_dGMkqWmmVXrHEMVMyxQQMY2RZcPE1OPNv-5IG3zztGr_7X4NbxMiJMcrkLkDWz4ZhuerzQol9uwNeok397CyQhNoxGP_yapgIs004baKWY4cjo-nBPTODI55j-GER0OL89-nhIUNb4zS3LREKTAxi00zmcxnGY78Ovo29noO02aC9RyVS5oHSLmC9yygoXMclErXtSFzIwthDNMlybPcpcFq2RgrNZKCxWMyazzVloZ-C5sRsP8HhAmhbRZmUsVf8lMIZWu88B9UM4rrUozANYteGUTITnqYvypeipldFIVnVS1TqqWA_h8_87Vio5j7ej9zjNV-jTnVe-WARzcP44LjTclpvHTGxzDS5SgyvmaMRHZIFmSEAP40sVIP83jVr1bb9V7eJG3YYlFlfuwuZjd-A_wzN4uLuazj22A_wVF1_3T
  priority: 102
  providerName: ProQuest
Title Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer
URI https://link.springer.com/article/10.1007/s11033-021-06458-y
https://www.proquest.com/docview/2577744390
https://www.proquest.com/docview/2535108623
https://www.proquest.com/docview/2661007066
Volume 48
WOSCitedRecordID wos000656441100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: Springer Nature - Connect here FIRST to enable access
  customDbUrl:
  eissn: 1573-4978
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004175
  issn: 0301-4851
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9sq7QvftSKV2tZwTddms0m-_FYjxZFPM-zyr2FzWYXipord1fL_fedySUNihb0ZSFkkh0mszu_sDPzA3ipTZUpISpulY88MyHjLk8dz22J3mxVEJVryCb0aGSmUztui8IWXbZ7dyTZ7NR9sZsg3jFKKaAea4avNmALw52h5Tj5_LWvhhRNe13C-jh5LtpSmT-_49dw1GPM345Fm2hz-uD_9HwI91t0yY7X7vAI7oR6F-6t-SZXu7A97OjdHsOnISnEEXt_Y22yFqtnNfczimZsMjpeMFdXbPxOvj9CJHj04-zjhBGB8ZVbsfOaUbtr2i5xPk-uM9-DL6cnZ8O3vOVX4F6afMnLiPguSi8yERMvVWlkVmY6cT5TlRM2d2mSVkn0RkchSmusMtG5xFfBa6-jfAKbqFh4CkxopX2Sp9rg75fLtLFlGmWIpgrGmtwNQHRmLnzbfJw4ML4XfdtkMluBZisasxWrAby6eeZi3XrjVumD7usV7TJcFLgfIbxFzJUM4MXNbTQ0nYq4OswuSUbmRDeVyltkEMVQYySlBvC6--r9NH_Xav_fxJ_BTto4DiVUHsDmcn4ZnsNd_3N5vpgfwoae6mY0h7D15mQ0nuDVh3RMo6YRl8E1Air5xw
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAiqXAgXULQWMBCewNnYedg4IVQtVV1uWpVqk3lLHD6mCZsvutlX-FL-xnjwagcTeeuAcJ35945mJZ-YDeCOkiRLGDE0T7WgkbURVzBWN09yjOU0sM6oimxDjsTw-Tidr8LvNhcGwyvZMrA5qM9P4j7zvoeUtFa8-g4_nvyiyRuHtakuhUcNiZMsr77ItPgw_-f19y_n-5-nggDasAlSHMl7S3HmrxoWaRcwFOkxyGUZ5JAKlo8QolsaKB9wETkvhGMtTmSbSKRVoY7XQwoX-u3fgrjcjuKxCBSddHiarCvuil-GnHbMmSadO1WPImoYBEVghTtLyT0XYWbd_XchWem7_4f-2Qo9gs7GoyV4tAo9hzRZbcL_m2Cy3YGPQUto9gW8DXArq_Y0fpAlQI8WsoHqGGpwcjfcWRBWGTIbhqO-t3_7Z9OsRQdLmK1WS04JgiW9UEb4_jeIyfwrfb2Vuz2DdD8xuA2EiETqIuZDe5VSRkGnOXWidNFamMlY9YO0GZ7opuI68Hz-zrlQ0giLzoMgqUGRlD97dvHNelxtZ2Xq3RULWHD2LrINBD17fPPYLjTdBqrCzC2wTxkixxcMVbbzlhsWgkqQH71tMdt38e1Q7q0f1CjYOpl8Os8PhePQcHvBKJDCAdBfWl_ML-wLu6cvl6WL-shIuAie3jdVr1HxcFA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8rzwKCAWChgJTmBt7CR-HBCqtqxYLVqWqki9pY5jSxWQLbtbqvw1fh2ePBqBxN564BwnccbfeGbimfkAXkpVJIKxgmphPU2US6hJuaGpzgOatXCsMDXZhJzN1NGRnm_Br64WBtMquz2x3qiLhcV_5MMAreCpBPMZDX2bFjHfH787_UGRQQpPWjs6jQYiU1edh_Bt9XayH9b6Fefj94ejD7RlGKA2Vuma5j54OD62LGE-srHIVZzkiYyMTURhmE4Nj3gReaukZyzXSgvljYls4ay00sfhuVfgqsSm5XXa4LyvyWR1k1-MOIIIUtYW7DRlewwZ1DA5ArvFKVr9aRR7T_evw9na5o3v_M_Sugu3W0-b7DWqcQ-2XLkD1xvuzWoHbo46qrv78HmEYqEhDvlK2sQ1Ui5Kahdo2cnBbG9FTFmQ-SSeDoNXPPx--OmAIJnzuanISUmw9TeajvA-i2q0fABfLuXbHsJ2mJh7BIRJIW2UcqlCKGoSqXTOfey8KpzSKjUDYN1iZ7ZtxI58IN-yvoU0AiQLAMlqgGTVAF5f3HPatCHZOHq3Q0XWbkmrrIfEAF5cXA6CxhMiU7rFGY6JU6Te4vGGMcGjwyZRQgzgTYfP_jX_ntXjzbN6DjcCRLOPk9n0CdzitXZgXukubK-XZ-4pXLM_1yer5bNazwgcXzZUfwNBgGTR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cross-talk+between+non-coding+RNAs+and+PI3K%2FAKT%2FmTOR+pathway+in+colorectal+cancer&rft.jtitle=Molecular+biology+reports&rft.au=Moafian%2C+Zeinab&rft.au=Maghrouni%2C+Abolfazl&rft.au=Soltani%2C+Arash&rft.au=Hashemy%2C+Seyed+Isaac&rft.date=2021-05-01&rft.issn=0301-4851&rft.volume=48&rft.issue=5+p.4797-4811&rft.spage=4797&rft.epage=4811&rft_id=info:doi/10.1007%2Fs11033-021-06458-y&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-4851&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-4851&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-4851&client=summon